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Abstract What is the first step in protein folding ^ hydrophobic
collapse (compaction) or secondary structure formation? It is
still not clear if the major driving force in protein folding is
hydrogen bonding or hydrophobic interactions or both. We
analyzed data on the conformational characteristics of 41
globular proteins in native and partially folded conformational
states. Our analysis shows that a good correlation exists between
relative decrease in hydrodynamic volume and increase in
secondary structure content. No compact equilibrium intermedi-
ates lacking secondary structure, or highly ordered non-compact
species, were found. This correlation provides experimental
support for the hypothesis that hydrophobic collapse occurs
simultaneously with formation of secondary structure in the early
stages of the protein folding. ß 2002 Federation of European
Biochemical Societies. Published by Elsevier Science B.V. All
rights reserved.
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1. Introduction
Understanding the initial events in protein folding is an
important prerequisite to solving the problem of protein
self-organization. Long-standing controversial questions in-
clude the nature of the ¢rst step in this process ^ hydrophobic
collapse (compaction) or secondary structure formation ^ and
the nature of the major driving force for protein folding ^
hydrogen bonding or hydrophobic interactions. As early as
1937 it was suggested that protein folding is directed mostly
by the formation of intramolecular hydrogen bonds [1]. Based
on this hypothesis, the secondary structure framework model,
postulating the stepwise formation of a rigid protein structure,
was elaborated. According to this model, the polypeptide
chain undergoes local folding to native-like elements of sec-
ondary structure, which direct subsequent folding through
di¡usion/collision processes [2,3]. On the other hand, it has
been noted that the hydrophobic attraction could be the dom-
inant force governing protein folding due to the fact that
hydrogen bonding to the solvent molecules would strongly
favor the unfolded state [4]. This hypothesis gave rise to the
hydrophobic collapse model, according to which strong hy-
drophobic attractions should ¢rst lead to non-speci¢c com-
paction of the polypeptide chain into a structure-less globule.
This step signi¢cantly reduces the conformational space and
consequently facilitates the formation of secondary and terti-
ary structure [5^8]. Discussions of these fundamentally di¡er-
ent competing models have generated considerable controv-
ersy over the years. To some extent this is reminiscent of the
debates concerning the old philosophical paradigm, which was
¢rst ^ the chicken or the egg?
Equilibrium partially folded conformations are usually con-
sidered stable counterparts of kinetic intermediates transiently
populated during protein refolding kinetics [9]. Many globular
proteins have been shown to exist in multiple stable confor-
mations, e.g. the native, molten globule, pre-molten globule,
and unfolded states [10^13]. In an attempt to elucidate the
mechanism involved in the initial events of protein folding,
the literature data on the conformational characteristics of
several globular proteins in native and partially folded con-
formational states have been analyzed. A good correlation
between relative decrease in hydrodynamic volume and in-
crease in secondary structure content has been established.
2. Materials and methods
Literature data on the equilibrium unfolding of globular proteins
have been analyzed to ¢nd a set of proteins for which secondary
structure and Stokes radii, RS, of native, unfolded and di¡erent par-
tially folded intermediates have been evaluated by far-UV circular
dichroism (CD) and hydrodynamic methods, respectively (see Table
1). The degree of compactness and the relative amounts of ordered
secondary structure have been calculated for di¡erent conformational
states. The degree of compactness was calculated as the decrease in
hydrodynamic volume of the given conformation relative to the vol-
ume of the unfolded conformation, (RUS /RS)
3. The relative amount of
ordered secondary structure was calculated for di¡erent conforma-
tional states from their far-UV CD spectra as the increase in negative
ellipticity at 222 nm, [a]222, relative to that of the unfolded conforma-
tion, [a]222/[a]U222.
3. Results and discussion
Our analysis of literature data on the equilibrium unfolding
of globular proteins revealed a set of 41 proteins for which
secondary structure and Stokes radii, RS, of native, unfolded
and di¡erent partially folded intermediates have been eval-
uated (see Table 1). Using this set of proteins, the correlation
between the degree of compactness and corresponding second-
ary structure content was analyzed. The results of this analysis
are presented in Fig. 1 as (RUS /RS)
3 (relative compactness) vs.
[a]222/[a]U222 (relative content of ordered secondary structure).
In this plot open and closed circles correspond to the data for
native globular proteins and their partially folded intermedi-
ates, respectively. Data for both classes of conformations (na-
tive states and various intermediate states) may be described
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Table 1
Structural characteristics of the analyzed proteins in di¡erent conformational states




Albebetin, de novo (7 760) U: 33 100 U: 24.1 [39]
MG: ^9 310 3.00 MG: 17.2 2.75
Albeferon, de novo (8 640) U: 33 000 U: 25.3 [39]
NP : 39 750 3.25 NP : 16.5 3.61
Ste¢n B (11 140) U: 31 350 U: 29.9
PMG: 32 850 2.11 PMG: 22.4 2.37 [40]
MG: 37 550 5.59 MG: 17.5 4.98
N: 36 350 4.70 N: 17.3 5.16
Cytochrome c (11 702) U: 31 250 U: 34
MG: 39 600 5.65 MG: 20 4.91 [41]
N: 317 000 7.94 N: 17 8.00
Prothymosin K, human (12 072) U: 32 000 U: 31.4
PMG: 34 760 2.38 PMG: 24.9 2.00 [42]
PMG: 34 100 2.56 PMG: 23.4 2.42
36^102 fragment of SNase R (12 099) U: 31 850 U: 31.2
PMG: 34 000 2.16 PMG: 23.6 2.31 [43]
K-Lactalbumin (human) (14 078) U: 34 000 U: 25.8
MG: 39 321 2.33 MG: 20.2 2.08 [44]
N: 310 640 2.96 N: 18.0 2.94
K-Synuclein, human (14 460) U: 31 300 U: 34.3 [45]
PMG: 32 500 1.92 PMG: 28.0 1.84
Intestinal fatty acid binding protein (15 076) and its
1^128 fragments (14 705)
U: 31 000 U: 36.4
U1ÿ128 : 31 000 U1ÿ128 : 36.1 [46]
Nmut : 35 600 5.60 Nmut : 20.6 5.51
Nwt : 36 200 6.20 Nwt : 20.0 6.03
N1ÿ128 : 36 200 6.20 N1ÿ128 : 19.7 6.15
PMG1ÿ128 : 28.0 1.93
28.0 1.98
PMGmut : 29.0 1.98
PMGwt : 29.0
Tumor suppressor protein P16 and its mutants
(16 532)
U: 31.6 U: 37.1
NH98P : 33.9 2.44 NH98P : 30.3 1.85 [47]
NR24P : 34.5 2.81 NR24P : 28.9 2.12
NP81L : 36.8 4.25 NP81L : 23.6 2.71
Nwt : 37.0 4.38 Nwt : 22.2 3.88
ND74N : 37.2 4.50 ND74N : 22.2 4.67
ND84N : 38.9 5.57 ND84N : 20.0 6.38
SNase (16 811) U: 33 000 U: 37.2
A1 : 37 800 2.60 A1 : 29.2 2.06 [16]
A2 : 39 830 3.06 A2 : 27.9 2.37
A3 : 313 884 4.60 A3 : 23.2 4.12
N: 314 120 5.69 N: 19.7 6.23
SNase F34W/W140F mutant (16 811) U: 32 500 U: 37.2
Mut: 38 000 3.20 Mut: 25.0 3.29 [48]
Wt: 312 000 4.80 Wt: 21.5 5.18
Apo-myoglobin (16 951) U: 35 000 U: 34.0
A1 : 312 000 2.40 A1 : 27.2 1.95 [49]
A2 : 315 000 3.00 A2 : 25.9 2.26
A3 : 319 000 3.80 A3 : 22.4 3.50
N: 322 000 5.65 N: 18.7 6.01
Dihydrofolate reductase (17 578) U: 3500 U: 37.6
MG: 32 800 5.60 MG: 22.5 4.67 [50]
N: 33 200 6.40 N: 20.5 6.17
Equine L-lactoglobulin (18 500) U: 31 450 U: 37.0
MG: 35 000 3.45 MG: 24.0 3.66 [51]
N: 36 950 4.79 N: 22.0 4.76
Apo£avodoxin (18 832) and its 1^149 fragment
(16 468)
Ufrag : 31 550 Ufrag : 37.7
MGfrag : 35 100 3.29 MGfrag : 24.3 3.73 [52]
MGfrag : 35 900 3.81 MGfrag : 23.8 3.98
N: 38 775 N: 22.9
Human nucleoside diphosphate kinase A (18 900) U: 31 100 U: 40.8
MG: 35 320 4.84 MG: 25.0 4.35 [53]
N: 37 580 6.88 N: 21.1 7.22
Nereis sarcoplasmic calcium binding protein (19 485) U: 31 750 U: 40.5
MG: 39 000 5.14 MG: 24.2 4.69 [54]
N: 311 000 6.28 N: 21.5 6.68
Adenylate kinase (21 658) U: 31100 U: 42.1
PMG: 32 300 2.09 PMG: 30.3 2.68 [55]
MG: 36 500 5.91 MG: 24.3 5.20
N: 38 200 7.45 N: 21.9 7.10
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Table 1 (continued)




Bovine growth hormone (21 745) U: 32 000 U: 37.0
MG: 37 000 3.50 MG: 26.0 2.88 [56]
N: 316 000 8.00 N: 18.0 8.69
Ovine placental lactogen (21 780) U: 33 168 U: 41.6
MG: 316 385 5.17 MG: 24.5 4.89 [57]
N: 319 750 6.23 N: 22.4 6.40
Peanut lectin monomer (25 000) U: 30.125 U: 45.9
MG: 30.711 5.69 MG: 26.4 5.26 [58]
N: 30.915 7.32 N: 23.4 7.54
Trypsinogen (25 425) U: 31 050 U: 38.1
PMG: 33 500 3.33 PMG: 24.1 3.95 [59]
N: 38 100 7.71 N: 19.8 7.12
Tryptophan synthase, K-subunit (28 724) U: 31 590 U: 53.7
PMG: 37 200 4.53 PMG: 33.9 3.97 [60]
N: 315 560 9.79 N: 24.2 10.93
L-Lactamase, Staphylococcus aureus (28 794) U: 31 250 U: 53.0
PMG: 36 000 4.80 PMG: 32.4 4.38 [10]
MG: 39 750 7.80 MG: 26.7 7.82
N: 310 900 8.72 N: 25.7 8.77
Bovine carbonic anhydrase B (28 800) U: 3600 U: 52.4
PMG: 33 000 5.00 PMG: 31.7 4.52 [12]
MG: 34 700 7.83 MG: 26.4 7.82
N: 23.0
RTEM L-lactamase (28 907) U: 32 000 U: 45.0 [61]
MG: 39 210 4.61 MG: 27.0 4.63
N: 312 100 6.05 N: 24.5 6.20
L-Lactamase, Bacillus cereus (29 061) U: 31 500 U: 51
MG: 311 000 7.31 MG: 26.5 7.12 [62]
N: 313 000 8.67 N: 24 9.59
Herpes simplex virus triplex protein VP23 (36 600) U: 31 300 U: 48.4 [63]
MG: 36 700 5.15 MG: 29.0 4.65
Actin, human (42 050) U: 31 250 U: 61.0 [64]
N: 313 000 10.40 N: 27.5 10.91
Ovalbumin (42 750) U: 32 200 U: 61.13 [65]
MG: 314 000 6.36 MG: 33.5 6.08
N: 314 000 6.36 N: 33.5 6.08
Glutaminyl-tRNA synthetase (47 000) U: 31 200 U: 60 [66]
MG: 34 500 3.75 MG: 38 3.94
N: 35 000 4.17 N: 36 4.63
Fetuin (48 000) U: 3750 U: 61.7 [67]
MG: 33 620 4.83 MG: 38.5 4.11
N: 35 750 7.66 N: 36.3 8.35
Interstitial collagenase (48 000) U: 31 200 U: 60.6 [68]
PMG: 34 950 4.13 PMG: 40.2 3.43
MG: 39 100 7.583 MG: 32.1 6.73
N: 312 500 10.42 N: 27.2 11.06
Co-polymer (48 800) U: 31250 U: 59.0 [69]
PMG: 32 500 2.00 PMG: 47.2 1.95
Bovine serum albumin (66 300) U: 31 650 U: 81.8 [70]
N: 324 180 14.65 N: 33.9 14.04
K-Fetoprotein, human (66 478) U: 31 450 U: 72.0
MG: 314 310 9.87 MG: 34.5 9.10 [70]
N: 315 230 10.50 N: 32.4 10.97
DnaK (68 983) U: 31 800 U: 73.0
PMG: 34 500 2.50 PMG: 53.1 2.60 [14,15]
MG: 316 000 8.89 MG: 36.3 8.13
N: 320 000 11.11 N: 32.5 11.33
Creatine kinase (2*43 112) U: 32 000 U: 61.2 [71,72]
PMG: 34 600 2.30 PMG: 49.4 1.90
MG: 310 800 5.40 MG: 33.7 5.99
Purple acid phosphatase (2*50 236) U: 3350 Ud : 101.6 [73]
Um : 71.7
N: 34 500 12.86 N: 41.7 14.46
Acetylcholinesterase (2*60 673) U: 31 100 U: 110.0 [74]
MG: 36 500 5.91 MG: 59.0 6.48
MG: 39 000 8.19 MG: 52.0 9.47
N: ^13 000 11.82 N: 49.0 11.31
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This means that the degree of compactness and the amount of
ordered secondary structure are highly correlated. The idea of
looking at the correlation between compactness and second-
ary structure content in proteins is not new. For example,
such data have been provided for di¡erent conformational
states of DnaK [14,15] and staphylococcal nuclease [16]. Fur-
thermore, Goto and coworkers have performed extensive in-
vestigations on the dependence of the radius of gyration on
helical content in apomyoglobin intermediates [17,18]. How-
ever, these prior works were focused on the description of
di¡erent conformational states for a single protein, whereas
the compilation in our study is more comprehensive and pro-
vides a broader picture. Thus, our analysis shows that there is
no compact equilibrium intermediate lacking secondary struc-
ture nor any highly ordered but non-compact species among
41 proteins from the data set. In the context of the early
stages of protein folding this suggests that hydrophobic col-
lapse and the formation of secondary structure occur simul-
taneously, rather than representing two independent and se-
quential processes.
This conclusion is in a good agreement with recent develop-
ments in the characterization of structural features of un-
folded proteins. It was long believed that proteins in strongly
denaturing conditions, such as high concentrations of urea or
guanidinium chloride, are random coils, i.e. ensemble of con-
formations involving only local interactions between residues.
This follows from Flory’s isolated pair model of the random
coil, which states that the backbone conformation of every
amino acid residue, as described by its P and i pair of back-
bone angles, is independent of the conformation of the neigh-
boring residues [19]. Interestingly, it has recently been shown
that steric clashes among residues separated by three to six
units eliminate a large number of backbone conformations in
certain regions of the Ramachandran map [20]. However, it is
well known in polymer physics that although local steric in-
teractions can reduce the number of allowed conformations,
they do not lead to any fundamental change in the exponen-
tial increase of accessible chain conformations as a function of
chain length [21]. In agreement with this suggestion, extensive
simulation studies by Derreumaux have shown that while di-
hedral biases increase the e⁄ciency of conformational
searches, they are not su⁄cient to fold proteins [22].
It is now becoming more and more evident that when a
protein unfolds, not all of its structure is lost [23^36]. More-
over, it has been shown that long-range order and native-like
spatial positioning and orientation of chain segments are
present, even in concentrated solutions of strong denaturants.
Thus, even the unfolded expanded polypeptide chain may
have signi¢cant native-like topology under these conditions
[36]. This means that the unfolded protein is predisposed to
adopt speci¢c backbone conformations rather than to become
a random coil, as Flory postulated in his isolated pair hypoth-
esis [19]. Therefore, favored backbone conformations already
preexist in the denatured protein, e¡ectively restricting the
number of states accessible to the unfolded polypeptide chain
[37]. Consequently, protein folding does not represent a ran-
dom search for the favorable native structure throughout the
enormously large conformational space. Instead, it can be
considered a directed run within a rather narrow conforma-
tional corridor, on which the ‘cementing’ of the preexisting
short- and long-range contacts occurs. In this view, the dis-
cussion of which happens ¢rst ^ compaction or secondary
structure formation ^ is no longer relevant. The only accept-
able scenario of the earliest stages of protein folding would be
that the hydrophobic collapse happens simultaneously with
the formation of secondary structure, a conclusion which is
in complete agreement with the results of our analysis. This
conclusion is supported by recent theoretical work of Kaya
and Chan [38], who found that the experimentally observed
thermodynamic and kinetic cooperativities in real proteins
most likely arise from a cooperative interplay between local
structural propensities and hydrophobic burial.
References
[1] Mirsky, A.E. and Pauling, L. (1937) Proc. Natl. Acad. Sci. USA
22, 439^441.
[2] Karplus, M. and Weaver, D.L. (1976) Nature 260, 404^406.
[3] Kim, P.S. and Baldwin, R.L. (1982) Annu. Rev. Biochem. 51,
459^473.
[4] Kauzmann, W. (1959) Adv. Protein Chem. 14, 1^24.
[5] Dill, K.A. (1985) Biochemistry 24, 1501^1510.
[6] Covell, D.G. and Jernigan, R.L. (1990) Biochemistry 29, 3287^
3294.
[7] Chan, H.S. and Dill, K.A. (1990) Proc. Natl. Acad. Sci. USA 87,
6388^6392.
[8] Gregoret, L.M. and Cohen, F.E. (1991) J. Mol. Biol. 219, 109^
122.
[9] Fink, A.L. (1995) Annu. Rev. Biophys. Biomol. Struct. 24, 495^
522.
[10] Uversky, V.N. and Ptitsyn, O.B. (1994) Biochemistry 33, 2782^
2791.
Fig. 1. Correlation between the degree of compactness (calculated
for di¡erent conformational states as the decrease in hydrodynamic
volume relative to the volume of the unfolded conformation) and
amount of ordered secondary structure (calculated for di¡erent con-
formational states from their far-UV CD spectra as the increase in
negative ellipticity at 222 nm, [a]222, relative to that of the unfolded
conformation). Open and closed symbols correspond to the data for
native globular proteins and their partially folded intermediates, re-
spectively.
FEBS 25888 28-3-02
V.N. Uversky, A.L. Fink/FEBS Letters 515 (2002) 79^8382
[11] Ptitsyn, O.B. (1995) Adv. Protein Chem. 47, 83^229.
[12] Uversky, V.N. and Ptitsyn, O.B. (1996) J. Mol. Biol. 255, 215^
228.
[13] Uversky, V.N. (1997) Protein Pept. Lett. 4, 355^367.
[14] Palleros, D.R., Shi, L., Reid, K.L. and Fink, A.L. (1993) Bio-
chemistry 32, 4314^4321.
[15] Palleros, D.R., Reid, K.L., McCarty, J.S., Walker, G.C. and
Fink, A.L. (1992) J. Biol. Chem. 267, 5279^5285.
[16] Uversky, V.N., Karnoup, A.S., Segel, D., Seshadri, S., Doniach,
S. and Fink, A.L. (1998) J. Mol. Biol. 278, 879^894.
[17] Nishii, I., Kataoka, M., Tokunaga, F. and Goto, Y. (1994) Bio-
chemistry 33, 4903^4909.
[18] Nishii, I., Kataoka, M. and Goto, Y. (1995) J. Mol. Biol. 250,
223^238.
[19] Flory, P.J. (1953) Principles of Polymer Chemistry, Cornell Uni-
versity Press, Ithaca, NY.
[20] Pappu, R.V., Srinivasan, R. and Rose, G.D. (2000) Proc. Natl.
Acad. Sci. USA 97, 12565^12570.
[21] Cantor, C.R. and Schimmel, P.R. (1980) Biophysical Chemistry
Part III, pp. 979^1018. W.H. Freeman, San Francisco.
[22] Derreumaux, P. (1997) J. Chem. Phys. 107, 1941^1947.
[23] Evans, P.A., Topping, K.D., Woolfson, D.N. and Dobson, C.M.
(1991) Proteins Struct. Funct. Genet. 9, 248^266.
[24] Neri, D., Billeter, M., Wider, G. and Wu«thrich, K. (1992) Science
257, 1559^1563.
[25] Logan, T.M., The¤riault, Y. and Fesik, S.W. (1994) J. Mol. Biol.
236, 637^648.
[26] Lumb, K.J. and Kim, P.S. (1994) J. Mol. Biol. 236, 412^420.
[27] Arcus, V.L., Vuilleumier, S., Freund, S.M.V., Bycroft, M. and
Fersht, A.R. (1995) J. Mol. Biol. 254, 305^321.
[28] Miranker, A.D. and Dobson, C.M. (1996) Curr. Opin. Struct.
Biol. 6, 31^42.
[29] Shortle, D. (1996) Curr. Opin. Struct. Biol. 6, 24^30.
[30] Wong, K.B., Freund, S.M.V. and Fersht, A.R. (1996) J. Mol.
Biol. 259, 805^818.
[31] Schwalbe, H., Feibig, K.M., Buck, M., Jones, J.A., Grimshaw,
S.B., Spencer, A., Glaser, S.J., Smith, L.J. and Dobson, C.M.
(1997) Biochemistry 39, 965^977.
[32] Blanco, F.J., Serrano, L. and Forman-Kay, J.D. (1998) J. Mol.
Biol. 284, 1153^1164.
[33] Kortemme, T., Kelly, M.J., Kay, L.E., Forman-Kay, J. and Ser-
rano, L. (1999) J. Mol. Biol. 297, 1217^1229.
[34] Garcia, P., Serrano, L., Durand, D., Rico, M. and Bruix, M.
(2001) Protein Sci. 10, 1100^1112.
[35] Plaxco, K.W. and Gross, M. (2001) Nature Struct. Biol. 8, 659^
660.
[36] Shortle, D. and Ackerman, M.S. (2001) Science 239, 487^489.
[37] Baldwin, R.L. and Zimm, B.H. (2000) Proc. Natl. Acad. Sci.
USA 97, 12391^12392.
[38] Kaya, H. and Chan, H.S. (2002) J. Mol. Biol. 315, 899^909.
[39] Aphasizheva, I.Yu., Dolgikh, D.A., Abdullaev, Z.K., Uversky,
V.N., Kirpichnikov, M.P. and Ptitsyn, O.B. (1998) FEBS Lett.
425, 101^104.
[40] Zerovnik, E., Jerala, R., KroonZitko, L., Turk, V. and Lohner,
K. (1997) Eur. J. Biochem. 245, 364^372.
[41] Bychkova, V.E., Dujsekina, A.E., Klenin, S.I., Tiktopulo, E.I.,
Uversky, V.N. and Ptitsyn, O.B. (1996) Biochemistry 35, 6058^
6063.
[42] Uversky, V.N., Gillespie, J.R., Millett, I.S., Khodyakova, A.V.,
Vasiliev, A.M., Chernovskaya, T.V., Vasilenko, R.N., Kozlov-
skaya, G.D., Dolgikh, D.A., Doniach, S., Fink, A.L. and Abra-
mov, V.M. (1999) Biochemistry 38, 15009^15016.
[43] Zhou, B., Tian, K. and Jing, G. (2000) Protein Eng. 13, 35^39.
[44] Kuwajima, K. (1996) FASEB J. 10, 102^109.
[45] Uversky, V.N., Li, J. and Fink, A.L. (2001) J. Biol. Chem. 276,
10737^10744.
[46] Clerico, E.M., Peisajovich, S.G., Ceolin, M., Ghiringhelli, P.D.
and Ermacora, M.R. (2000) Biochim. Biophys. Acta 1476, 203^
218.
[47] Tang, K.S., Guralnick, B.J., Wang, W.K., Fersht, A.R. and It-
zahaki, L.S. (1999) J. Mol. Biol. 285, 1869^1886.
[48] Li, Y. and Jing, G. (2000) J. Biochem. (Tokyo) 128, 739^744.
[49] Fink, A.L., Oberg, K.A. and Seshadri, S. (1998) Fold. Des. 3,
19^25.
[50] Uversky, V.N., Kutyshenko, V.P., Protasova, N.Yu., Rogov,
V.V., Vassilenko, K.S. and Gudkov, A.T. (1996) Protein Sci. 5,
1844^1851.
[51] Ikeguchi, M., Kato, S.-C., Shimizu, A. and Sugai, S. (1997) Pro-
teins 27, 567^575.
[52] Maldonado, S., Jimenez, M.A., Langdon, G.M. and Sancho, J.
(1998) Biochemistry 37, 10589^10596.
[53] Lascu, I., Schaertl, S., Wang, C., Sarger, C., Giartosio, A.,
Briand, G., Lacombe, M.L. and Konrad, M. (1997) J. Biol.
Chem. 272, 15599^15602.
[54] Christova, P., Cox, J.A. and Craescu, C.T. (2000) Proteins 40,
177^184.
[55] Zhang, Y.-L., Zhou, J.-M. and Tsou, C.-L. (1996) Biochim. Bio-
phys. Acta 1295, 239^244.
[56] Brems, D.N. and Havel, H.A. (1989) Proteins 5, 93^95.
[57] Cymes, G.D., Grosman, C., Del¢no, J.M. and Wolfenstein, T.C.
(1996) Protein Sci. 5, 2074^2079.
[58] Reddy, G.B., Srinivas, V.R., Ahmad, N. and Surolia, A. (1999)
J. Biol. Chem. 274, 4500^4512.
[59] Martins, N.F. and Santoro, M.M. (1999) Braz. J. Med. Biol. Res.
32, 673^682.
[60] Gualfetti, P.J., Iwakura, M., Lee, J.C., Kihara, H., Bilsel, O.,
Zitzewitz, J.A. and Matthews, C.R. (1999) Biochemistry 38,
13367^13378.
[61] Sarkar, D. and DasGupta, C. (1996) Biochim. Biophys. Acta
1296, 85^94.
[62] Goto, Y. and Fink, A.L. (1989) Biochemistry 28, 945^952.
[63] Kirkitadze, M.D., Barlow, P.N., Price, N.C., Kelly, S.M., Bou-
tell, C.J., Rixon, F.J. and McClelland, D.A. (1998) J. Virol. 72,
10066^10072.
[64] Kuznetsova, I.M., Biktashev, A.G., Khaitlina, S.Y., Vassilenko,
K.S., Turoverov, K.K. and Uversky, V.N. (1999) Biophys. J. 77,
2788^2800.
[65] Koseki, T., Kitabatake, N. and Doi, E. (1988) J. Biochem. (To-
kyo) 103, 425^430.
[66] Das, B.K., Bhattacharyya, T. and Roy, S. (1995) Biochemistry
34, 5242^5247.
[67] Wang, C., Lascu, I. and Giartosio, A. (1998) Biochemistry 37,
8457^8464.
[68] Zhang, Y. and Gray, R.D. (1996) J. Biol. Chem. 271, 8015^8021.
[69] Karnoup, A.S. and Uversky, V.N. (1997) Macromolecules 30,
7427^7434.
[70] Uversky, V.N., Narizhneva, N.V., Ivanova, T.V. and Tomashev-
ski, A.Y. (1997) Biochemistry 44, 13638^13645.
[71] Clottes, E., Leydier, C., Couthon, F., Marcillat, O. and Vial, C.
(1997) Biochim. Biophys. Acta 1338, 37^46.
[72] Kuznetsova, I.M., Stepanenko, O.V., Turoverov, K.K., Zhu, L.,
Zhou, J.-M., Fink, A.L. and Uversky, V.N. (2002) Biochim. Bio-
phys. Acta (in press).
[73] Cashikar, A.G. and Rao, N.M. (1996) Biochim. Biophys. Acta
1296, 78^84.
[74] Kreimer, D.I., Shin, I., Shnyrov, V.L., Villar, E., Silman, I. and
Weiner, L. (1996) Protein Sci. 5, 1852^1864.
FEBS 25888 28-3-02
V.N. Uversky, A.L. Fink/FEBS Letters 515 (2002) 79^83 83
